US Broker Ratings

Agios Pharmaceuticals (AGIO) Stock Analysis: High Growth Potential Amidst Revenue Surge and Positive Ratings

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) stands out in the biotechnology sector with its focus on pioneering treatments for rare genetic diseases through advancements in cellular metabolism. With a market capitalization..

Innoviva, Inc. (INVA) Stock Analysis: Exploring a 53.57% Potential Upside for Investors

Innoviva, Inc. (NASDAQ: INVA), a key player in the biotechnology sector, presents a compelling opportunity for investors, with a potential upside of 53.57% based on its average target price. Headquartered..

U.S. Physical Therapy, Inc. (USPH): Investor Outlook Reveals 39.81% Potential Upside

U.S. Physical Therapy, Inc. (USPH), a prominent player in the healthcare sector, offers a promising investment opportunity with a compelling potential upside of 39.81%. With a market capitalization of $1.15..

MiMedx Group, Inc (MDXG) Stock Analysis: A Potential 82% Upside in the Biotech Sector

MiMedx Group, Inc (NASDAQ: MDXG) is making waves in the biotechnology sector with a compelling growth narrative and an impressive potential upside of 82.63%. This Marietta, Georgia-based company, specializing in..

Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: Exploring a 32.83% Potential Upside for Investors

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) stands as a compelling player within the biotechnology sector, particularly for investors interested in companies that focus on rare and orphan diseases. With a market..

Xenon Pharmaceuticals Inc. (XENE) Stock Analysis: Why a 23.94% Potential Upside Has Investors Buzzing

Xenon Pharmaceuticals Inc. (NASDAQ: XENE), a prominent player in the biotechnology sector focusing on neurological and psychiatric disorders, has been capturing the attention of investors with its promising clinical pipeline..

ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: Unveiling a 186.67% Potential Upside in the Biotech Sector

ARS Pharmaceuticals, Inc. (SPRY), a dynamic player in the biotechnology sector, is capturing investor attention with a remarkable potential upside of 186.67%. This San Diego-based biopharmaceutical company is at the..

Harmony Biosciences Holdings (HRMY): Investor Outlook on a Promising 18.66% Upside

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) has emerged as a compelling player in the biotechnology sector, specifically within the healthcare industry. With a market capitalization of $2.24 billion, this U.S.-based..

Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Navigating a 8.60% Potential Upside in the Healthcare Sector

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a pivotal player in the medical devices industry, stands as a noteworthy contender in the healthcare sector with a market capitalization of $1.41 billion...

PACS Group, Inc. (PACS) Stock Analysis: A Promising 13.82% Upside in the Healthcare Sector

PACS Group, Inc. (PACS), a notable player in the healthcare sector, has been making waves in the medical care facilities industry with its impressive financial growth and strategic operations. Headquartered..

CONMED Corporation (CNMD) Investor Outlook: Evaluating a Potential 23.74% Upside Amidst Market Challenges

CONMED Corporation (NASDAQ: CNMD), a prominent player in the healthcare sector, specifically within the medical devices industry, is capturing investor interest with its compelling growth potential. The company’s current market..

Select Medical Holdings Corp (SEM) Stock Analysis: A 23% Potential Upside with Strong Analyst Support

Select Medical Holdings Corporation (NYSE: SEM) is capturing the attention of healthcare investors with its robust market presence and promising growth potential. Operating in the healthcare sector, SEM is a..

Adaptive Biotechnologies (ADPT) Stock Analysis: Exploring a Potential 32.82% Upside for Investors

Adaptive Biotechnologies Corporation (NASDAQ: ADPT) has been making waves in the biotechnology sector with its innovative immune medicine platform aimed at diagnosing and treating various diseases. Based in Seattle, Washington,..

Aveanna Healthcare Holdings Inc (AVAH) Stock Analysis: A 15.76% Upside Potential in the Healthcare Sector

Aveanna Healthcare Holdings Inc (AVAH), a prominent player in the healthcare sector, is capturing investor attention with its robust growth prospects and diverse service offerings. As a key provider of..

Supernus Pharmaceuticals, Inc. (SUPN): Investor Outlook Reveals a Promising 28.29% Upside Potential

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) is capturing the attention of investors in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a market capitalization of $2.7..

Surgery Partners, Inc. (SGRY) Stock Analysis: Exploring a 53.87% Upside Potential

Surgery Partners, Inc. (NASDAQ: SGRY) operates within the healthcare sector, specializing in medical care facilities across the United States. With a market capitalization of approximately $2.16 billion, the company provides..

Dynavax Technologies Corporation (DVAX) Stock Analysis: Navigating a 75% Potential Upside

For individual investors keeping a keen eye on the healthcare sector, Dynavax Technologies Corporation (NASDAQ: DVAX) presents an intriguing opportunity. The biopharmaceutical company, based in Emeryville, California, is known for..

89bio, Inc. (ETNB) Stock Analysis: Exploring a Potential 104% Upside with Innovative Biotech Solutions

89bio, Inc. (NASDAQ: ETNB) is carving out a niche in the biotech sector with its focus on liver and cardio-metabolic diseases. Headquartered in San Francisco, 89bio is at the forefront..

GoodRx Holdings, Inc. (GDRX) Stock Analysis: Exploring an 81.99% Upside Potential in the Health Information Services Sector

GoodRx Holdings, Inc. (GDRX), a prominent player in the health information services industry, is making waves with an impressive potential upside of 81.99%. As a company dedicated to providing consumers..

ICU Medical, Inc. (ICUI): Investor Outlook Reveals 25.78% Potential Upside Amidst Robust Analyst Ratings

ICU Medical, Inc. (NASDAQ: ICUI) stands as a significant player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $3.55 billion, the..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds